Global Growth Hormone Drug Market Growth 2023-2029

March 2023 | 102 pages | ID: G1644E95D1E2EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “Growth Hormone Drug Industry Forecast” looks at past sales and reviews total world Growth Hormone Drug sales in 2022, providing a comprehensive analysis by region and market sector of projected Growth Hormone Drug sales for 2023 through 2029. With Growth Hormone Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Growth Hormone Drug industry.

This Insight Report provides a comprehensive analysis of the global Growth Hormone Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Growth Hormone Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Growth Hormone Drug market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Growth Hormone Drug and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Growth Hormone Drug.

The global Growth Hormone Drug market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Growth Hormone Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Growth Hormone Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Growth Hormone Drug is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Growth Hormone Drug players cover Merck, Roche, Novartis, Novo Nordisk, Eli Lilly, Pfizer, LG, Aeterna Zentaris and Biogenomics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Growth Hormone Drug market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Norditropin
  • Genotropin
  • Humatrope
  • Saizen
  • Nutropin
Segmentation by application
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck
  • Roche
  • Novartis
  • Novo Nordisk
  • Eli Lilly
  • Pfizer
  • LG
  • Aeterna Zentaris
  • Biogenomics
  • Critical Pharmaceuticals
Key Questions Addressed in this Report

What is the 10-year outlook for the global Growth Hormone Drug market?

What factors are driving Growth Hormone Drug market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Growth Hormone Drug market opportunities vary by end market size?

How does Growth Hormone Drug break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Growth Hormone Drug Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Growth Hormone Drug by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Growth Hormone Drug by Country/Region, 2018, 2022 & 2029
2.2 Growth Hormone Drug Segment by Type
  2.2.1 Norditropin
  2.2.2 Genotropin
  2.2.3 Humatrope
  2.2.4 Saizen
  2.2.5 Nutropin
2.3 Growth Hormone Drug Sales by Type
  2.3.1 Global Growth Hormone Drug Sales Market Share by Type (2018-2023)
  2.3.2 Global Growth Hormone Drug Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Growth Hormone Drug Sale Price by Type (2018-2023)
2.4 Growth Hormone Drug Segment by Application
  2.4.1 Retail Pharmacies
  2.4.2 Hospital Pharmacies
  2.4.3 Online Pharmacies
2.5 Growth Hormone Drug Sales by Application
  2.5.1 Global Growth Hormone Drug Sale Market Share by Application (2018-2023)
  2.5.2 Global Growth Hormone Drug Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Growth Hormone Drug Sale Price by Application (2018-2023)

3 GLOBAL GROWTH HORMONE DRUG BY COMPANY

3.1 Global Growth Hormone Drug Breakdown Data by Company
  3.1.1 Global Growth Hormone Drug Annual Sales by Company (2018-2023)
  3.1.2 Global Growth Hormone Drug Sales Market Share by Company (2018-2023)
3.2 Global Growth Hormone Drug Annual Revenue by Company (2018-2023)
  3.2.1 Global Growth Hormone Drug Revenue by Company (2018-2023)
  3.2.2 Global Growth Hormone Drug Revenue Market Share by Company (2018-2023)
3.3 Global Growth Hormone Drug Sale Price by Company
3.4 Key Manufacturers Growth Hormone Drug Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Growth Hormone Drug Product Location Distribution
  3.4.2 Players Growth Hormone Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR GROWTH HORMONE DRUG BY GEOGRAPHIC REGION

4.1 World Historic Growth Hormone Drug Market Size by Geographic Region (2018-2023)
  4.1.1 Global Growth Hormone Drug Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Growth Hormone Drug Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Growth Hormone Drug Market Size by Country/Region (2018-2023)
  4.2.1 Global Growth Hormone Drug Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Growth Hormone Drug Annual Revenue by Country/Region (2018-2023)
4.3 Americas Growth Hormone Drug Sales Growth
4.4 APAC Growth Hormone Drug Sales Growth
4.5 Europe Growth Hormone Drug Sales Growth
4.6 Middle East & Africa Growth Hormone Drug Sales Growth

5 AMERICAS

5.1 Americas Growth Hormone Drug Sales by Country
  5.1.1 Americas Growth Hormone Drug Sales by Country (2018-2023)
  5.1.2 Americas Growth Hormone Drug Revenue by Country (2018-2023)
5.2 Americas Growth Hormone Drug Sales by Type
5.3 Americas Growth Hormone Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Growth Hormone Drug Sales by Region
  6.1.1 APAC Growth Hormone Drug Sales by Region (2018-2023)
  6.1.2 APAC Growth Hormone Drug Revenue by Region (2018-2023)
6.2 APAC Growth Hormone Drug Sales by Type
6.3 APAC Growth Hormone Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Growth Hormone Drug by Country
  7.1.1 Europe Growth Hormone Drug Sales by Country (2018-2023)
  7.1.2 Europe Growth Hormone Drug Revenue by Country (2018-2023)
7.2 Europe Growth Hormone Drug Sales by Type
7.3 Europe Growth Hormone Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Growth Hormone Drug by Country
  8.1.1 Middle East & Africa Growth Hormone Drug Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Growth Hormone Drug Revenue by Country (2018-2023)
8.2 Middle East & Africa Growth Hormone Drug Sales by Type
8.3 Middle East & Africa Growth Hormone Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Growth Hormone Drug
10.3 Manufacturing Process Analysis of Growth Hormone Drug
10.4 Industry Chain Structure of Growth Hormone Drug

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Growth Hormone Drug Distributors
11.3 Growth Hormone Drug Customer

12 WORLD FORECAST REVIEW FOR GROWTH HORMONE DRUG BY GEOGRAPHIC REGION

12.1 Global Growth Hormone Drug Market Size Forecast by Region
  12.1.1 Global Growth Hormone Drug Forecast by Region (2024-2029)
  12.1.2 Global Growth Hormone Drug Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Growth Hormone Drug Forecast by Type
12.7 Global Growth Hormone Drug Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Growth Hormone Drug Product Portfolios and Specifications
  13.1.3 Merck Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Roche
  13.2.1 Roche Company Information
  13.2.2 Roche Growth Hormone Drug Product Portfolios and Specifications
  13.2.3 Roche Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Roche Main Business Overview
  13.2.5 Roche Latest Developments
13.3 Novartis
  13.3.1 Novartis Company Information
  13.3.2 Novartis Growth Hormone Drug Product Portfolios and Specifications
  13.3.3 Novartis Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Novartis Main Business Overview
  13.3.5 Novartis Latest Developments
13.4 Novo Nordisk
  13.4.1 Novo Nordisk Company Information
  13.4.2 Novo Nordisk Growth Hormone Drug Product Portfolios and Specifications
  13.4.3 Novo Nordisk Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Novo Nordisk Main Business Overview
  13.4.5 Novo Nordisk Latest Developments
13.5 Eli Lilly
  13.5.1 Eli Lilly Company Information
  13.5.2 Eli Lilly Growth Hormone Drug Product Portfolios and Specifications
  13.5.3 Eli Lilly Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Eli Lilly Main Business Overview
  13.5.5 Eli Lilly Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Growth Hormone Drug Product Portfolios and Specifications
  13.6.3 Pfizer Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 LG
  13.7.1 LG Company Information
  13.7.2 LG Growth Hormone Drug Product Portfolios and Specifications
  13.7.3 LG Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 LG Main Business Overview
  13.7.5 LG Latest Developments
13.8 Aeterna Zentaris
  13.8.1 Aeterna Zentaris Company Information
  13.8.2 Aeterna Zentaris Growth Hormone Drug Product Portfolios and Specifications
  13.8.3 Aeterna Zentaris Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Aeterna Zentaris Main Business Overview
  13.8.5 Aeterna Zentaris Latest Developments
13.9 Biogenomics
  13.9.1 Biogenomics Company Information
  13.9.2 Biogenomics Growth Hormone Drug Product Portfolios and Specifications
  13.9.3 Biogenomics Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Biogenomics Main Business Overview
  13.9.5 Biogenomics Latest Developments
13.10 Critical Pharmaceuticals
  13.10.1 Critical Pharmaceuticals Company Information
  13.10.2 Critical Pharmaceuticals Growth Hormone Drug Product Portfolios and Specifications
  13.10.3 Critical Pharmaceuticals Growth Hormone Drug Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Critical Pharmaceuticals Main Business Overview
  13.10.5 Critical Pharmaceuticals Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Growth Hormone Drug Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Growth Hormone Drug Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Norditropin
Table 4. Major Players of Genotropin
Table 5. Major Players of Humatrope
Table 6. Major Players of Saizen
Table 7. Major Players of Nutropin
Table 8. Global Growth Hormone Drug Sales by Type (2018-2023) & (K MT)
Table 9. Global Growth Hormone Drug Sales Market Share by Type (2018-2023)
Table 10. Global Growth Hormone Drug Revenue by Type (2018-2023) & ($ million)
Table 11. Global Growth Hormone Drug Revenue Market Share by Type (2018-2023)
Table 12. Global Growth Hormone Drug Sale Price by Type (2018-2023) & (USD/MT)
Table 13. Global Growth Hormone Drug Sales by Application (2018-2023) & (K MT)
Table 14. Global Growth Hormone Drug Sales Market Share by Application (2018-2023)
Table 15. Global Growth Hormone Drug Revenue by Application (2018-2023)
Table 16. Global Growth Hormone Drug Revenue Market Share by Application (2018-2023)
Table 17. Global Growth Hormone Drug Sale Price by Application (2018-2023) & (USD/MT)
Table 18. Global Growth Hormone Drug Sales by Company (2018-2023) & (K MT)
Table 19. Global Growth Hormone Drug Sales Market Share by Company (2018-2023)
Table 20. Global Growth Hormone Drug Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Growth Hormone Drug Revenue Market Share by Company (2018-2023)
Table 22. Global Growth Hormone Drug Sale Price by Company (2018-2023) & (USD/MT)
Table 23. Key Manufacturers Growth Hormone Drug Producing Area Distribution and Sales Area
Table 24. Players Growth Hormone Drug Products Offered
Table 25. Growth Hormone Drug Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Growth Hormone Drug Sales by Geographic Region (2018-2023) & (K MT)
Table 29. Global Growth Hormone Drug Sales Market Share Geographic Region (2018-2023)
Table 30. Global Growth Hormone Drug Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Growth Hormone Drug Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Growth Hormone Drug Sales by Country/Region (2018-2023) & (K MT)
Table 33. Global Growth Hormone Drug Sales Market Share by Country/Region (2018-2023)
Table 34. Global Growth Hormone Drug Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Growth Hormone Drug Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Growth Hormone Drug Sales by Country (2018-2023) & (K MT)
Table 37. Americas Growth Hormone Drug Sales Market Share by Country (2018-2023)
Table 38. Americas Growth Hormone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Growth Hormone Drug Revenue Market Share by Country (2018-2023)
Table 40. Americas Growth Hormone Drug Sales by Type (2018-2023) & (K MT)
Table 41. Americas Growth Hormone Drug Sales by Application (2018-2023) & (K MT)
Table 42. APAC Growth Hormone Drug Sales by Region (2018-2023) & (K MT)
Table 43. APAC Growth Hormone Drug Sales Market Share by Region (2018-2023)
Table 44. APAC Growth Hormone Drug Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Growth Hormone Drug Revenue Market Share by Region (2018-2023)
Table 46. APAC Growth Hormone Drug Sales by Type (2018-2023) & (K MT)
Table 47. APAC Growth Hormone Drug Sales by Application (2018-2023) & (K MT)
Table 48. Europe Growth Hormone Drug Sales by Country (2018-2023) & (K MT)
Table 49. Europe Growth Hormone Drug Sales Market Share by Country (2018-2023)
Table 50. Europe Growth Hormone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Growth Hormone Drug Revenue Market Share by Country (2018-2023)
Table 52. Europe Growth Hormone Drug Sales by Type (2018-2023) & (K MT)
Table 53. Europe Growth Hormone Drug Sales by Application (2018-2023) & (K MT)
Table 54. Middle East & Africa Growth Hormone Drug Sales by Country (2018-2023) & (K MT)
Table 55. Middle East & Africa Growth Hormone Drug Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Growth Hormone Drug Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Growth Hormone Drug Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Growth Hormone Drug Sales by Type (2018-2023) & (K MT)
Table 59. Middle East & Africa Growth Hormone Drug Sales by Application (2018-2023) & (K MT)
Table 60. Key Market Drivers & Growth Opportunities of Growth Hormone Drug
Table 61. Key Market Challenges & Risks of Growth Hormone Drug
Table 62. Key Industry Trends of Growth Hormone Drug
Table 63. Growth Hormone Drug Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Growth Hormone Drug Distributors List
Table 66. Growth Hormone Drug Customer List
Table 67. Global Growth Hormone Drug Sales Forecast by Region (2024-2029) & (K MT)
Table 68. Global Growth Hormone Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Growth Hormone Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 70. Americas Growth Hormone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Growth Hormone Drug Sales Forecast by Region (2024-2029) & (K MT)
Table 72. APAC Growth Hormone Drug Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Growth Hormone Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 74. Europe Growth Hormone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Growth Hormone Drug Sales Forecast by Country (2024-2029) & (K MT)
Table 76. Middle East & Africa Growth Hormone Drug Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Growth Hormone Drug Sales Forecast by Type (2024-2029) & (K MT)
Table 78. Global Growth Hormone Drug Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Growth Hormone Drug Sales Forecast by Application (2024-2029) & (K MT)
Table 80. Global Growth Hormone Drug Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Merck Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 82. Merck Growth Hormone Drug Product Portfolios and Specifications
Table 83. Merck Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 84. Merck Main Business
Table 85. Merck Latest Developments
Table 86. Roche Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 87. Roche Growth Hormone Drug Product Portfolios and Specifications
Table 88. Roche Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 89. Roche Main Business
Table 90. Roche Latest Developments
Table 91. Novartis Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 92. Novartis Growth Hormone Drug Product Portfolios and Specifications
Table 93. Novartis Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 94. Novartis Main Business
Table 95. Novartis Latest Developments
Table 96. Novo Nordisk Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 97. Novo Nordisk Growth Hormone Drug Product Portfolios and Specifications
Table 98. Novo Nordisk Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 99. Novo Nordisk Main Business
Table 100. Novo Nordisk Latest Developments
Table 101. Eli Lilly Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 102. Eli Lilly Growth Hormone Drug Product Portfolios and Specifications
Table 103. Eli Lilly Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 104. Eli Lilly Main Business
Table 105. Eli Lilly Latest Developments
Table 106. Pfizer Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 107. Pfizer Growth Hormone Drug Product Portfolios and Specifications
Table 108. Pfizer Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 109. Pfizer Main Business
Table 110. Pfizer Latest Developments
Table 111. LG Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 112. LG Growth Hormone Drug Product Portfolios and Specifications
Table 113. LG Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 114. LG Main Business
Table 115. LG Latest Developments
Table 116. Aeterna Zentaris Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 117. Aeterna Zentaris Growth Hormone Drug Product Portfolios and Specifications
Table 118. Aeterna Zentaris Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 119. Aeterna Zentaris Main Business
Table 120. Aeterna Zentaris Latest Developments
Table 121. Biogenomics Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 122. Biogenomics Growth Hormone Drug Product Portfolios and Specifications
Table 123. Biogenomics Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 124. Biogenomics Main Business
Table 125. Biogenomics Latest Developments
Table 126. Critical Pharmaceuticals Basic Information, Growth Hormone Drug Manufacturing Base, Sales Area and Its Competitors
Table 127. Critical Pharmaceuticals Growth Hormone Drug Product Portfolios and Specifications
Table 128. Critical Pharmaceuticals Growth Hormone Drug Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 129. Critical Pharmaceuticals Main Business
Table 130. Critical Pharmaceuticals Latest Developments

LIST OF FIGURES

Figure 1. Picture of Growth Hormone Drug
Figure 2. Growth Hormone Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Growth Hormone Drug Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Growth Hormone Drug Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Growth Hormone Drug Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Norditropin
Figure 10. Product Picture of Genotropin
Figure 11. Product Picture of Humatrope
Figure 12. Product Picture of Saizen
Figure 13. Product Picture of Nutropin
Figure 14. Global Growth Hormone Drug Sales Market Share by Type in 2022
Figure 15. Global Growth Hormone Drug Revenue Market Share by Type (2018-2023)
Figure 16. Growth Hormone Drug Consumed in Retail Pharmacies
Figure 17. Global Growth Hormone Drug Market: Retail Pharmacies (2018-2023) & (K MT)
Figure 18. Growth Hormone Drug Consumed in Hospital Pharmacies
Figure 19. Global Growth Hormone Drug Market: Hospital Pharmacies (2018-2023) & (K MT)
Figure 20. Growth Hormone Drug Consumed in Online Pharmacies
Figure 21. Global Growth Hormone Drug Market: Online Pharmacies (2018-2023) & (K MT)
Figure 22. Global Growth Hormone Drug Sales Market Share by Application (2022)
Figure 23. Global Growth Hormone Drug Revenue Market Share by Application in 2022
Figure 24. Growth Hormone Drug Sales Market by Company in 2022 (K MT)
Figure 25. Global Growth Hormone Drug Sales Market Share by Company in 2022
Figure 26. Growth Hormone Drug Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Growth Hormone Drug Revenue Market Share by Company in 2022
Figure 28. Global Growth Hormone Drug Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Growth Hormone Drug Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Growth Hormone Drug Sales 2018-2023 (K MT)
Figure 31. Americas Growth Hormone Drug Revenue 2018-2023 ($ Millions)
Figure 32. APAC Growth Hormone Drug Sales 2018-2023 (K MT)
Figure 33. APAC Growth Hormone Drug Revenue 2018-2023 ($ Millions)
Figure 34. Europe Growth Hormone Drug Sales 2018-2023 (K MT)
Figure 35. Europe Growth Hormone Drug Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Growth Hormone Drug Sales 2018-2023 (K MT)
Figure 37. Middle East & Africa Growth Hormone Drug Revenue 2018-2023 ($ Millions)
Figure 38. Americas Growth Hormone Drug Sales Market Share by Country in 2022
Figure 39. Americas Growth Hormone Drug Revenue Market Share by Country in 2022
Figure 40. Americas Growth Hormone Drug Sales Market Share by Type (2018-2023)
Figure 41. Americas Growth Hormone Drug Sales Market Share by Application (2018-2023)
Figure 42. United States Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Growth Hormone Drug Sales Market Share by Region in 2022
Figure 47. APAC Growth Hormone Drug Revenue Market Share by Regions in 2022
Figure 48. APAC Growth Hormone Drug Sales Market Share by Type (2018-2023)
Figure 49. APAC Growth Hormone Drug Sales Market Share by Application (2018-2023)
Figure 50. China Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Growth Hormone Drug Sales Market Share by Country in 2022
Figure 58. Europe Growth Hormone Drug Revenue Market Share by Country in 2022
Figure 59. Europe Growth Hormone Drug Sales Market Share by Type (2018-2023)
Figure 60. Europe Growth Hormone Drug Sales Market Share by Application (2018-2023)
Figure 61. Germany Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Growth Hormone Drug Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Growth Hormone Drug Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Growth Hormone Drug Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Growth Hormone Drug Sales Market Share by Application (2018-2023)
Figure 70. Egypt Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Growth Hormone Drug Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Growth Hormone Drug in 2022
Figure 76. Manufacturing Process Analysis of Growth Hormone Drug
Figure 77. Industry Chain Structure of Growth Hormone Drug
Figure 78. Channels of Distribution
Figure 79. Global Growth Hormone Drug Sales Market Forecast by Region (2024-2029)
Figure 80. Global Growth Hormone Drug Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Growth Hormone Drug Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Growth Hormone Drug Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Growth Hormone Drug Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Growth Hormone Drug Revenue Market Share Forecast by Application (2024-2029)


More Publications